Perspectives On 340B: An Interview With Lilly’s Derek Asay
Executive Summary
Lilly is one of the more active manufacturers when it comes to overseeing provider compliance with rules for the 340B drug discount program. Derek Asay, Lilly senior director of government strategy for federal accounts, spoke to “The Pink Sheet” about the company’s approach.